World's Best Scientists 2026 revealed!
Stephen J. Clarke

Stephen J. Clarke

D-Index & Metrics

Medicine

D-Index
87
Citations
34618
World Ranking
13487
National Ranking
443

Overview

Stephen J. Clarke is affiliated with the University of Sydney in Australia. Their research primarily spans the field of Medicine, with a focus on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery, and Epidemiology.

The scientist's work covers several main topics, including:

  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Lung Cancer Research Studies
  • Neuroendocrine Tumor Research Advances
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies

Frequent publication venues for their research include:

  • Journal of Clinical Oncology
  • PLoS ONE
  • Frontiers in Oncology
  • Lung Cancer
  • Cancers

Notable recent papers by Stephen J. Clarke include:

  • Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study (2023), published in Journal of Clinical Oncology
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer (2022), published in Nature Medicine
  • Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial (2020), published in Annals of Oncology
  • First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors (2023), published in Cancer Immunology Immunotherapy
  • Australian recommendations for the management of hepatocellular carcinoma: a consensus statement (2020), published in The Medical Journal of Australia

Throughout their career, Clarke has collaborated frequently with other researchers, including:

  • Nick Pavlakis
  • Malinda Itchins
  • Connie I. Diakos
  • Anthony J. Gill
  • David Chan

Best Publications

  • Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

    Leonard B. Saltz;Stephen Clarke;Eduardo Díaz-Rubio;Werner Scheithauer

  • Cancer-related inflammation and treatment effectiveness

    Connie I Diakos;Kellie A Charles;Donald C McMillan;Stephen J Clarke

  • The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer

    Graeme J.K. Guthrie;Kellie A. Charles;Campbell S.D. Roxburgh;Paul G. Horgan

  • Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

    Jim Cassidy;Stephen Clarke;Eduardo Díaz-Rubio;Werner Scheithauer

  • Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

    Aimery de Gramont;Eric Van Cutsem;Hans Joachim Schmoll;Josep Tabernero

  • Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

    Nico van Zandwijk;Nick Pavlakis;Steven C Kao;Anthony Linton

  • Clinical Pharmacokinetics of Docetaxel

    Stephen J. Clarke;Laurent P. Rivory

  • Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

    W Chua;K A Charles;V E Baracos;S J Clarke;S J Clarke

  • A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

    M J Proctor;D C McMillan;D S Morrison;C D Fletcher

  • Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial

    Bob T. Li;Ronglai Shen;Darren Buonocore;Zachary T. Olah

  • Regulation of Drug Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

    Edward T. Morgan;Kerry B. Goralski;Micheline Piquette-Miller;Kenneth W. Renton

  • First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    Harpreet S Wasan;Peter Gibbs;Navesh K Sharma;Julien Taieb

  • High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy

    Steven C.H. Kao;Nick Pavlakis;Rozelle Harvie;Janette L. Vardy

  • Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: A systematic review

    E. Davis;B. Oh;P. Butow;Barbara Mullan

  • Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial

    B. Oh;B. Oh;P. Butow;Barbara Mullan;S. Clarke

  • XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

    J Cassidy;S Clarke;E Díaz-Rubio;W Scheithauer

  • The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.

    Joseph C. Y. Chan;David L. Chan;Connie I. Diakos;Alexander Engel

  • Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy

    Kellie A Slaviero;Stephen J Clarke;Laurent P Rivory

  • Inflammation and cancer: causes and consequences.

    M M Moore;W Chua;K A Charles;S J Clarke

  • Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

    Daniel G. Haller;Jim Cassidy;Stephen J. Clarke;David Cunningham

Frequent Co-Authors

Anthony J. Gill
Anthony J. Gill University of Sydney
Michael Boyer
Michael Boyer University of Utah
Andrew J. McLachlan
Andrew J. McLachlan University of Sydney
Phyllis Butow
Phyllis Butow University of Sydney
John R. Zalcberg
John R. Zalcberg Monash University
David Goldstein
David Goldstein University of New South Wales
Michael J. Solomon
Michael J. Solomon Royal Prince Alfred Hospital
Paul Mitchell
Paul Mitchell University of Sydney
Christopher Liddle
Christopher Liddle University of Sydney
Gregory R. Pond
Gregory R. Pond McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens the door to various related degrees and career pathways that can be explored online. Many students consider nursing schools that don't require teas or hesi for admission, making entry into nursing programs more accessible for those seeking a flexible and straightforward nursing education.

For those interested in the administrative side of healthcare, enrolling in a healthcare administration degree online accredited can provide essential management skills and career advancement opportunities within hospitals, clinics, or public health organizations.

Registered nurses interested in advancing their clinical practice can take advantage of rn to np programs online, which enable them to bridge educational gaps and become nurse practitioners through flexible and efficient pathways.

Another growing field is nutrition. Earning an online degree in nutrition opens up opportunities in dietetics, wellness coaching, and public health nutrition, responding to the increasing demand for qualified nutrition professionals.

Exploring these alternative pathways can complement or provide a valuable alternative to traditional medical studies, offering flexibility and diverse roles within the healthcare sector.

Best Scientists Citing Stephen J. Clarke

Trending Scientists

Recently Published Articles